Tucson Lifestyle Magazine features Dr. Mateja de Leonni Stanonik

TUCSON, Ariz. - July 10, 2024 - PRLog -- In the new issue, Tucson Lifestyle magazine presents Dr. Mateja de Leonni Stanonik as "The Face of Alzheimer's Treatment." This celebrates Dr. de Leonni's exceptional contributions to the field of neurology, her service to the Tucson-area community, and her dedication to advancing research and treatment options for neurological disorders.

Dr. de Leonni, a Tucson-based neurologist with an extensive research background, has made significant strides in understanding and treating neurological conditions. In the feature article, she provides a brief overview of Alzheimer's treatment options, offering hope and guidance to patients and their families.

"I am honored to be featured by Tucson Lifestyle magazine," said Dr. de Leonni. "My goal is to continue to push the boundaries of neurological research and provide the best possible care for my patients. Alzheimer's disease is a challenging condition, but with continued research and advancements in treatment, we can make a significant impact on the lives of those affected."

Alzheimer's affects approximately 6 percent of all people age 65 and older and is the most common cause of dementia. The exact cause of Alzheimer's is elusive. According to current scientific opinions, it is caused by an abnormal build-up of proteins in and around brain cells. As the FDA approves new drugs aimed at mitigating the effects of this debilitating disease, Dr. de Leonni Stanonik emphasizes a comprehensive approach that also includes lifestyle modifications.

The approval of new Alzheimer's drugs marks a significant milestone in the fight against this neurodegenerative disease. These medications, such as lecanemab and aducanumab (discontinued by the manufacturer in 2024) target the amyloid plaques in the brain that are characteristic of Alzheimer's. An encouraging clinical trial tested a new drug, LM11A-31, to possibly increase the brain's resilience to Alzheimer-driven changes. See https://medicalxpress.com/news/2024-05-results-human-clinical-trial-early.html

Dr. de Leonni Stanonik cautions that "in all medical matters, one should not act based solely on information found on the internet, but instead review the issues with the medical doctor who has the patient's medical history and has personally examined the patient." Website: https://alzheimersresearch.info/